BioTuesdays

ObsEva names Brian O’Callaghan as CEO

ObsEva Logo

ObsEva (NASDAQ:OBSV) appointed Brian O’Callaghan as CEO, effective Dec. 1.

He succeeds ObsEva’s co-founder, Ernest Loumaye, M.D., Ph.D., who is retiring from his role as CEO but will remain a director of the company.

Mr. O’Callaghan was most recently CEO of Petra Pharma, and is currently a director at Decoy Biosystems and Aquavit Pharmaceuticals.

“It has been a tremendous honor to serve as the CEO of ObsEva since founding the company and I am incredibly proud of everything our team has accomplished in the past seven years,” Dr. Loumaye said in a statement.

“I am delighted to be succeeded by Brian whose wealth of experience will greatly benefit ObsEva as we move forward and evolve, and I am committed to supporting him and ObsEva during this transition and in the future,” he added.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.